Reforms put in place by the Department of Veterans Affairs to prevent the routine purchase of pharmaceuticals in violation of federal contracting laws have improved the VA procurement system but failed to eliminate improper practices.
After two years, the Veterans Affairs (VA) issued its final rule on promotion by pharmaceutical sales representatives.
The U.S. Department of Veterans Affairs may have improperly spent billions of dollars on purchases including pharmaceuticals.
An on-site infectious disease consultation service at a Veterans Affairs (VA) long-term care facility led to a significant decrease in the overall use of antimicrobials, oral agents, and especially fluoroquinolones.